Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vipul Organics filed a quarterly statement confirming no deviation in the use of proceeds from its preferential issue of equity shares for the quarter ended December 31, 2025. The company raised ₹27.54 crore on December 22, 2025, down from the originally approved ₹35.24 crore because certain proposed allottees did not participate. The revised allocation stands at ₹10.66 crore for upgrading manufacturing facilities and expanding capacity, ₹10 crore for repaying long-term bank debt, and ₹6.88 crore for general corporate purposes. The original objects approved by shareholders in the October 31, 2025 EGM remain unchanged, only the amounts were scaled down. As of the quarter end, no funds have been utilised and the entire amount is temporarily parked in a fixed deposit.
This is a routine compliance filing with no negative signals—no deviation from stated purpose, and idle funds are sitting safely in a fixed deposit. Shareholders may note that deployment of capital is yet to begin roughly a month after allotment, and the smaller-than-planned issue size trims the expansion kitty by about ₹5.8 crore.